Open AccessRegarding “Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasms”
Author(s) -
Yoshida Go J.
Publication year - 2018
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2018-0148
Subject(s) - medicine , chemotherapy , immune surveillance , immune system , oncology , ovarian cancer , programmed cell death , cancer research , cancer , immunology , apoptosis , chemistry , biochemistry
New treatment strategies for platinum‐resistant recurrent ovarian cancer are needed. Programmed cell death‐1 (PD‐1) signaling is a new target of antitumor therapy that involves immune reactivation; however, its antitumor effect on subsequent chemotherapy is unclear. Two representative cases are described here.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom